Pharma granulation LCI launched Dome Ex, a continuous wet granulation system for pharmaceutical manufacturing, signaling a direct sales opportunity into pharma process equipment and process intensification.

Nederman backing As part of the Nederman Group since 2012, LCI benefits from a larger corporate platform that can open cross-sell opportunities across process industries and provide credibility when engaging with potential customers.

Process focus With liquids applications (evaporation, drying, filtration) and solids applications (extrusion, spheronization, feeding, pelleting), target process industries that require integrated solids and liquids handling to uncover combined equipment solutions.

Growth signals Revenue range ($25M–$50M) and a mid-sized team (51–200 employees) indicate a scalable, relationship-driven sales approach with potential for upsell into larger process facilities or expansions through partnerships.

Strategic partnerships Past collaborations, such as the Buss-SMS-Canzler partnership, suggest appetite for distributor and technology co-marketing. Leverage this to identify regional distributors and accelerate entry into new markets.